Cargando…
Proteomics for Early Detection of Non-Muscle-Invasive Bladder Cancer: Clinically Useful Urine Protein Biomarkers
Bladder cancer is the fourth most common cancer in men, and most cases are non-muscle-invasive. A high recurrence rate is a critical problem in non-muscle-invasive bladder cancer. The availability of few urine tests hinders the effective detection of superficial and small bladder tumors. Cystoscopy...
Autores principales: | Ahn, Jae-Hak, Kang, Chan-Koo, Kim, Eun-Mee, Kim, Ah-Ram, Kim, Aram |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8950253/ https://www.ncbi.nlm.nih.gov/pubmed/35330146 http://dx.doi.org/10.3390/life12030395 |
Ejemplares similares
-
Cell-Free microRNA-214 From Urine as a Biomarker for Non-Muscle-Invasive Bladder Cancer
por: Kim, Sung Min, et al.
Publicado: (2013) -
Urine Proteomics and Biomarkers in Renal Disease
por: Kim, Min Jeong, et al.
Publicado: (2011) -
Discovery of urine biomarkers for lupus nephritis via quantitative and comparative proteome analysis
por: Kwon, Oh Chan, et al.
Publicado: (2021) -
Next-Generation Proteomics–Based Discovery, Verification, and Validation of Urine Biomarkers for Bladder Cancer Diagnosis
por: Suh, Jungyo, et al.
Publicado: (2022) -
Altered Proteome of Extracellular Vesicles Derived from Bladder Cancer Patients Urine
por: Lee, Jingyun, et al.
Publicado: (2018)